Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 8.090\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCOC(=O)C1=C(C)N(C)C(=S)NC1c1ccc(Cl)cc1
b CCOc1ccc(NC(=O)NCc2cccn2C)cc1
c COc1cccc(C(=O)NN2CC(O)=C(c3nc4ccccc4n3C)C2=N)c1
Answer: c. COc1cccc(C(=O)NN2CC(O)=C(c3nc4ccccc4n3C)C2=N)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(C(=O)NN2CC(O)=C(c3nc4ccccc4n3C)C2=N)c1
COc1cccc(C(=O)NN2CC(O)=C(c3nc4ccccc4n3C)C2=N)c1
N-[3-hydroxy-5-imino-4-(1-methylbenzimidazol-2-yl)-2H-pyrrol-1-yl]-3-methoxybenzamide